Australia markets closed

Enwei Pharmaceutical Co., Ltd. (301331.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.87-0.16 (-0.73%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.27B
Enterprise value 1.93B
Trailing P/E 34.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.97
Price/book (mrq)2.10
Enterprise value/revenue 2.51
Enterprise value/EBITDA 24.12

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-14.42%
S&P500 52-week change 323.20%
52-week high 334.99
52-week low 318.89
50-day moving average 326.30
200-day moving average 326.57

Share statistics

Avg vol (3-month) 31.25M
Avg vol (10-day) 3842.15k
Shares outstanding 5102.89M
Implied shares outstanding 6102.89M
Float 818.74M
% held by insiders 175.15%
% held by institutions 11.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 43.63%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4166.86%
Dividend date 3N/A
Ex-dividend date 423 May 2024
Last split factor 21.48:1
Last split date 323 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.73%
Operating margin (ttm)5.47%

Management effectiveness

Return on assets (ttm)3.15%
Return on equity (ttm)5.93%

Income statement

Revenue (ttm)767.87M
Revenue per share (ttm)11.00
Quarterly revenue growth (yoy)-8.60%
Gross profit (ttm)N/A
EBITDA 106.66M
Net income avi to common (ttm)67.07M
Diluted EPS (ttm)0.65
Quarterly earnings growth (yoy)-69.60%

Balance sheet

Total cash (mrq)371.53M
Total cash per share (mrq)5.38
Total debt (mrq)34.28M
Total debt/equity (mrq)3.18%
Current ratio (mrq)3.63
Book value per share (mrq)15.64

Cash flow statement

Operating cash flow (ttm)89.57M
Levered free cash flow (ttm)-86.31M